Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2005 | 1 |
2010 | 3 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Tyrosine phosphatase inhibitor-3 sensitizes melanoma and colon cancer to biotherapeutics and chemotherapeutics.
Mol Cancer Ther. 2010 Aug;9(8):2287-96. doi: 10.1158/1535-7163.MCT-10-0159. Epub 2010 Aug 3.
Mol Cancer Ther. 2010.
PMID: 20682647
Free PMC article.
PRL-2 increases Epo and IL-3 responses in hematopoietic cells.
Akiyama S, Dhavan D, Yi T.
Akiyama S, et al.
Blood Cells Mol Dis. 2010 Apr 15;44(4):209-14. doi: 10.1016/j.bcmd.2010.02.013. Epub 2010 Mar 11.
Blood Cells Mol Dis. 2010.
PMID: 20226699
Free PMC article.
Item in Clipboard
Sodium stibogluconate interacts with IL-2 in anti-Renca tumor action via a T cell-dependent mechanism in connection with induction of tumor-infiltrating macrophages.
Fan K, Zhou M, Pathak MK, Lindner DJ, Altuntas CZ, Tuohy VK, Borden EC, Yi T.
Fan K, et al.
J Immunol. 2005 Nov 15;175(10):7003-8. doi: 10.4049/jimmunol.175.10.7003.
J Immunol. 2005.
PMID: 16272361
Item in Clipboard
Novel SHP-1 inhibitors tyrosine phosphatase inhibitor-1 and analogs with preclinical anti-tumor activities as tolerated oral agents.
Kundu S, Fan K, Cao M, Lindner DJ, Zhao ZJ, Borden E, Yi T.
Kundu S, et al.
J Immunol. 2010 Jun 1;184(11):6529-36. doi: 10.4049/jimmunol.0903562. Epub 2010 Apr 26.
J Immunol. 2010.
PMID: 20421638
Free PMC article.
Item in Clipboard
Cite
Cite